$250 | Single User
$500 | Site License
$750 | Global License

Riemser Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 24-07-2018]

Published by Global Data: 24 Jul 2018 | 215332 | In Stock

Introduction

Summary

Riemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a distributor of lifecycle management products. The company offers analgesics products, cardiovascular products, over-the-counter medicines, prescription drugs and dental products. It provides medical products for the treatment of infectious diseases, obesity, rheumatology, tuberculosis therapy, neurology, oncology and dermatological disorders such as psoriasis, acromycosis, acne, and herpes. Riemser also offers nutritional supplements. The company has research and development alliances with research institutes, universities, colleges and hospitals across Europe. It has operations in Germany, France and the UK. Riemser is headquartered in Greifswald, Germany.

Riemser Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Riemser Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 24-07-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

    Riemser Pharma GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

    Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

    Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

    Riemser Pharma GmbH, Medical Devices Deals, 2012 to YTD 2018 10

    Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

    Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deal Details 12

    Asset Purchase 12

    Riemser Pharma Acquires CNS Portfolio from Dolorgiet 12

    RIEMSER Arzneimittel Acquires Worldwide Rights Of Ostac From Roche 13

    Private Equity 14

    Ardian May Sell Riemser Pharma for USD494.3 Million 14

    AXA Private Equity Completes Acquisition Of Riemser Arzneimittel 16

    Partnerships 18

    Riemser Pharma Enters into Licensing Agreement with Eisai 18

    Asset Transactions 19

    Dermapharm Acquires Hyperthermic Medical Devices Business Unit from Riemser Pharma 19

    Acquisition 20

    Riemser Pharma to Acquire Intrapharm Labs 20

    Riemser Pharma Acquires Keocyt 21

    Riemser Arzneimittel To Acquire 49% Stake In anwerina 22

    Riemser Pharma GmbH - Key Competitors 23

    Riemser Pharma GmbH - Key Employees 24

    Riemser Pharma GmbH - Locations And Subsidiaries 25

    Head Office 25

    Other Locations & Subsidiaries 25

    Appendix 26

    Methodology 26

    About GlobalData 26

    Contact Us 26

    Disclaimer 26

List Of Tables
in Riemser Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 24-07-2018]

List of Tables

Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Key Facts 2

Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Riemser Pharma GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Riemser Pharma GmbH, Deals By Therapy Area, 2012 to YTD 2018 8

Riemser Pharma GmbH, Medical Devices Deals, 2012 to YTD 2018 10

Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Riemser Pharma Acquires CNS Portfolio from Dolorgiet 12

RIEMSER Arzneimittel Acquires Worldwide Rights Of Ostac From Roche 13

Ardian May Sell Riemser Pharma for USD494.3 Million 14

AXA Private Equity Completes Acquisition Of Riemser Arzneimittel 16

Riemser Pharma Enters into Licensing Agreement with Eisai 18

Dermapharm Acquires Hyperthermic Medical Devices Business Unit from Riemser Pharma 19

Riemser Pharma to Acquire Intrapharm Labs 20

Riemser Pharma Acquires Keocyt 21

Riemser Arzneimittel To Acquire 49% Stake In anwerina 22

Riemser Pharma GmbH, Key Competitors 23

Riemser Pharma GmbH, Key Employees 24

Riemser Pharma GmbH, Other Locations 25

Riemser Pharma GmbH, Subsidiaries 25

List Of Figures, Charts and Diagrams
in Riemser Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 24-07-2018]

List of Figures

Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Riemser Pharma GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Riemser Pharma GmbH, Medical Devices Deals, 2012 to YTD 2018 10

Additional Details

Publisher

Global Data

Publisher Information

Reference

215332 | GDPH173526D

Number of Pages

26

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Riemser Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryRiemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a healthcare products prov...
14 Mar 2018 by Global Data USD $250 More Info
Riemser Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryRiemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a healthcare products prov...
28 Nov 2017 by Global Data USD $250 More Info
Riemser Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryRiemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a healthcare products prov...
24 Aug 2017 by Global Data USD $250 More Info
Riemser Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryRiemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a healthcare products prov...
24 Aug 2017 by Global Data USD $250 More Info
Riemser Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryRiemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a healthcare products prov...
12 May 2017 by Global Data USD $250 More Info
Riemser Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryRiemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a specialty pharmaceutical...
21 Feb 2017 by Global Data USD $250 More Info
Riemser Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryRiemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a specialty pharmaceutical...
30 Nov 2016 by Global Data USD $250 More Info
Riemser Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryRiemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a specialty pharmaceutical...
10 May 2016 by Global Data USD $250 More Info
Riemser Arzneimittel AG – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
SummaryMarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments r...
15 Apr 2016 by Marketline USD $350 More Info
Riemser Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryRiemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a specialty pharmaceutical...
15 Mar 2016 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Riemser Pharma GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 24-07-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data